Edap Tms (NASDAQ:EDAP) Upgraded to “Hold” at StockNews.com

Edap Tms (NASDAQ:EDAP) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday.

Separately, HC Wainwright reiterated a “buy” rating and issued a $19.00 target price on shares of Edap Tms in a report on Monday, July 22nd.

Edap Tms Price Performance

EDAP stock opened at $4.19 on Tuesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.62 and a quick ratio of 2.00. The company’s 50-day moving average is $5.03 and its 200-day moving average is $6.23. The stock has a market capitalization of $155.47 million, a PE ratio of -7.76 and a beta of 0.45. Edap Tms has a 1 year low of $3.60 and a 1 year high of $8.57.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Thursday, May 16th. The medical equipment provider reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.03). Edap Tms had a negative return on equity of 31.44% and a negative net margin of 30.12%. The firm had revenue of $16.13 million during the quarter, compared to the consensus estimate of $16.22 million. Equities research analysts expect that Edap Tms will post -0.51 EPS for the current fiscal year.

Institutional Trading of Edap Tms

Several institutional investors and hedge funds have recently made changes to their positions in the company. Virtu Financial LLC purchased a new stake in shares of Edap Tms during the first quarter valued at approximately $82,000. Miracle Mile Advisors LLC purchased a new position in Edap Tms in the first quarter worth $136,000. Roubaix Capital LLC bought a new position in Edap Tms in the 1st quarter valued at $169,000. Finally, Commonwealth Equity Services LLC increased its position in shares of Edap Tms by 5.9% during the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after purchasing an additional 4,000 shares during the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.